Cambridge Advisors Inc. Abbott Laboratories Transaction History

Cambridge Advisors Inc.

$416 Million
Q1 2024

A detailed history of Cambridge Advisors Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cambridge Advisors Inc. holds 7,270 shares of ABT stock, worth $750,264. This represents 0.2% of its overall portfolio holdings.

Number of Shares

7,270

Previous 7,745 6.13%

Holding current value

$750,264

Previous $852,000 3.05%

% of portfolio

0.2%

Previous 0.22%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $52,022 - $57,456	-475 Reduced 6.13%	7,270 $826,000
Q4 2023 Jan 16, 2024	SELL	$90.19 - $110.4 $18,038 - $22,080	-200 Reduced 2.52%	7,745 $852,000
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $75,081 - $83,656	-745 Reduced 8.57%	7,945 $866,000
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $19,012 - $22,304	-200 Reduced 2.25%	8,690 $0
Q2 2022 Jul 18, 2022	SELL	$102.07 - $123.37 $14,800 - $17,888	-145 Reduced 1.6%	8,890 $966,000

Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $5,701 - $6,952	-50 Reduced 0.55%	9,035 $1.07 Million
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $81,662 - $90,342	-700 Reduced 7.15%	9,085 $1.07 Million
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $32,265 - $37,981	-305 Reduced 3.02%	9,785 $1.13 Million
Q3 2020 Oct 15, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 0.98%	10,090 $1.1 Million
Q4 2019 Jan 28, 2020	BUY	$78.51 - $87.4 $800,016 - $890,606	10,190 New	10,190 $885,000
Q3 2019 Oct 25, 2019	SELL	$81.84 - $88.74 $848,271 - $919,790	-10,365 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $41,906 - $48,875	-575 Reduced 5.26%	10,365 $872,000
Q1 2018 Apr 18, 2018	SELL	$56.27 - $63.62 $3,938 - $4,453	-70 Reduced 0.64%	10,940 $656,000
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $529,140 - $590,576	11,010	11,010 $587,000

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.

Account

Cambridge Advisors Inc. Abbott Laboratories Transaction History